Global Digital Therapeutics Market – Global Industry Analysis and Forecast (2017-2024) _ by Sales Channel, by Application, and by Geography

Global Digital Therapeutics Market – Global Industry Analysis and Forecast (2017-2024) _ by Sales Channel, by Application, and by Geography

Market Scenario

Global Digital Therapeutics Market is expected to reach US$ 816.55 Mn by 2024 from US$ 113.32 Mn in 2016 at CAGR of 28.0% (Detailed analysis of the market CAGR is provided in the report). Global Digital Therapeutics Market Digital Therapeutics stands for health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects and can be used to treat type II diabetes, Alzheimer’s disease, dementia, congestive heart failure, chronic obstructive pulmonary disease, and asthma. Factors that drive the growth of the digital therapeutics market are growing need to control healthcare costs and upsurge in the incidence of chronic diseases. However, lack of awareness toward digital therapeutics acts as a key restraint to the market growth. On the contrary, high growth potential in the developing economies is anticipated to offer significant growth opportunities. Global Digital Therapeutics Market is segmented by sales channel, application, and geography. Sales channel segment is bifurcated as B2B and B2C. B2B segment is expected to lead the market growth. This growth is attributed to the rising adoption of digital therapeutics in this segment, especially among payers and employers. In terms of application, obesity segment is projected to be one of the most lucrative segments during the forecast period, owing to rise in obese population and increase in the number of cases where treatments are done via smartphone applications for obese population. Various applications covered under the scope of this report are preventive applications and treatment/care-related applications. Preventive application segment is expected to dominate the market growth owing to, increasing government initiatives to increase the focus on preventive healthcare and a rising consensus among policymakers. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. North America dominated the global market in 2017 and is expected to retain its dominance throughout the forecast period. Continuous reforms in countries to address a lack of proper infrastructure and maintain sustainable growth through financial inclusion in this region will fuel the Digital Therapeutics Market in Asia Specific region. Some of the key players in the digital therapeutics market are Proteus Digital Health, Inc., Omada Health Inc., WellDoc, Inc., 2Morrow, Inc., Livongo Health, Propeller Health, Twine Health, Inc., Canary Health, Inc. Noom Inc., and Medtronic Plc. The other players operating in the value chain are BiogenoQ Inc., Claritas Mindsciences, Jintronix Inc., Virta Health Corp., and Dthera Science.

Global Digital Therapeutics Market, By Sales Channel

• B2B o Caregivers o Patients • B2C o Providers o Payers o Pharmaceutical Companies o Employers o Other Buyers

Global Digital Therapeutics Market, By Application

• Preventive Applications o Prediabetes o Obesity • Treatment/Care-Related Applications o Diabetes o Central Nervous System (CNS) Disorders o Chronic Respiratory Diseases (CRD) o Musculoskeletal Disorders o Cardiovascular Diseases o Smoking Cessation o Medication Adherence o Other Applications

Global Digital Therapeutics Market, By Geography:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America

Key Players in the Global Digital Therapeutics Market Are:

• Evolent Health, Inc. • Pear Therapeutics, Inc. • WellDoc Inc. • Nanobiosym, Inc. • Twine Health, Inc. • Mango Health Inc. • Canary Health Inc. • 2morrow Inc. • Propeller Health • Ginger.Io, Inc. • Noom Inc. • Livongo Health • Welldoc, Inc. • Omada Health, Inc. • Proteus Digital Health, Inc. Available Customization Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client. Global Healthcare Mobility Solutions Market

Table of Contents

Global Digital Therapeutics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Digital Therapeutics Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Digital Therapeutics Market Analysis and Forecast 5.1. Global Digital Therapeutics Market Analysis and Forecast 5.2. Global Digital Therapeutics Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Digital Therapeutics Market Analysis and Forecast, by Sales Channel 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Digital Therapeutics Market Value Share Analysis, by Sales Channel 6.4. Market Size (US$ Mn) Forecast, by Sales Channel 6.5. Global Digital Therapeutics Market Analysis, by Sales Channel 6.6. Digital Therapeutics Market Attractiveness Analysis, by Sales Channel 7. Global Digital Therapeutics Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Digital Therapeutics Market Value Share Analysis, by Application 7.3. Market Size (US$ Mn) Forecast, by Application 7.4. Global Digital Therapeutics Market Analysis, by Application 7.5. Global Digital Therapeutics Market Attractiveness Analysis, by Application 8. Global Digital Therapeutics Market Analysis, by Region 8.1. Global Digital Therapeutics Market Value Share Analysis, by Region 8.2. Market Size (US$ Mn) Forecast, by Region 8.3. Global Digital Therapeutics Market Attractiveness Analysis, by Region 9. North America Digital Therapeutics Market Analysis 9.1. Key Findings 9.2. North America Digital Therapeutics Market Overview 9.3. North America Digital Therapeutics Market Value Share Analysis, by Sales Channel 9.4. North America Digital Therapeutics Market Forecast, by Sales Channel 9.4.1. B2B 9.4.2. B2C 9.5. North America Digital Therapeutics Market Value Share Analysis, by Application 9.6. North America Digital Therapeutics Market Forecast, by Application 9.6.1. Preventive Applications 9.6.2. Treatment/Care-Related Applications 9.7. North America Digital Therapeutics Market Value Share Analysis, by Country 9.8. North America Digital Therapeutics Market Forecast, by Country 9.8.1. U.S. 9.8.2. Canada 9.9. North America Digital Therapeutics Market Analysis, by Country 9.10. U.S. Digital Therapeutics Market Forecast, by Sales Channel 9.10.1. B2B 9.10.2. B2C 9.11. U.S. Digital Therapeutics Market Forecast, by Application 9.11.1. Preventive Applications 9.11.2. Treatment/Care-Related Applications 9.12. Canada Digital Therapeutics Market Forecast, by Sales Channel 9.12.1. B2B 9.12.2. B2C 9.13. Canada Digital Therapeutics Market Forecast, by Application 9.13.1. Preventive Applications 9.13.2. Treatment/Care-Related Applications 9.14. North America Digital Therapeutics Market Attractiveness Analysis 9.14.1. By Sales Channel 9.14.2. By Application 9.15. PEST Analysis 10. Europe Digital Therapeutics Market Analysis 10.1. Key Findings 10.2. Europe Digital Therapeutics Market Overview 10.3. Europe Digital Therapeutics Market Value Share Analysis, by Sales Channel 10.4. Europe Digital Therapeutics Market Forecast, by Sales Channel 10.4.1. B2B 10.4.2. B2C 10.5. Europe Digital Therapeutics Market Value Share Analysis, by Application 10.6. Europe Digital Therapeutics Market Forecast, by Application 10.6.1. Preventive Applications 10.6.2. Treatment/Care-Related Applications 10.7. Europe Digital Therapeutics Market Value Share Analysis, by Country 10.8. Europe Digital Therapeutics Market Forecast, by Country 10.8.1.1. Germany 10.8.1.2. U.K. 10.8.1.3. France 10.8.1.4. Italy 10.8.1.5. Spain 10.8.1.6. Rest of Europe 10.9. Europe Digital Therapeutics Market Analysis, by Country/ Sub-region 10.10. Germany Digital Therapeutics Market Forecast, by Sales Channel 10.10.1. B2B 10.10.2. B2C 10.11. Germany Digital Therapeutics Market Forecast, by Application 10.11.1. Preventive Applications 10.11.2. Treatment/Care-Related Applications 10.12. U.K. Digital Therapeutics Market Forecast, by Sales Channel 10.12.1. B2B 10.12.2. B2C 10.13. U.K. Digital Therapeutics Market Forecast, by Application 10.13.1. Preventive Applications 10.13.2. Treatment/Care-Related Applications 10.14. France Digital Therapeutics Market Forecast, by Sales Channel 10.14.1. B2B 10.14.2. B2C 10.15. France Digital Therapeutics Market Forecast, by Application 10.15.1. Preventive Applications 10.15.2. Treatment/Care-Related Applications 10.16. Italy Digital Therapeutics Market Forecast, by Sales Channel 10.16.1. B2B 10.16.2. B2C 10.17. Italy Digital Therapeutics Market Forecast, by Application 10.17.1. Preventive Applications 10.17.2. Treatment/Care-Related Applications 10.18. Spain Digital Therapeutics Market Forecast, by Sales Channel 10.18.1. B2B 10.18.2. B2C 10.19. Spain Digital Therapeutics Market Forecast, by Application 10.19.1. Preventive Applications 10.19.2. Treatment/Care-Related Applications 10.20. Rest of Europe Digital Therapeutics Market Forecast, by Sales Channel 10.20.1. B2B 10.20.2. B2C 10.21. Rest of Europe Digital Therapeutics Market Forecast, by Application 10.21.1. Preventive Applications 10.21.2. Treatment/Care-Related Applications 10.22. Europe Digital Therapeutics Market Attractiveness Analysis 10.22.1. By Sales Channel 10.22.2. By Application 10.23. PEST Analysis 11. Asia Pacific Digital Therapeutics Market Analysis 11.1. Key Findings 11.2. Asia Pacific Digital Therapeutics Market Overview 11.3. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Sales Channel 11.4. Asia Pacific Digital Therapeutics Market Forecast, by Sales Channel 11.4.1. B2B 11.4.2. B2C 11.5. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Application 11.6. Asia Pacific Digital Therapeutics Market Forecast, by Application 11.6.1. Preventive Applications 11.6.2. Treatment/Care-Related Applications 11.7. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Country 11.8. Asia Pacific Digital Therapeutics Market Forecast, by Country 11.8.1. China 11.8.2. India 11.8.3. Japan 11.8.4. ASEAN 11.8.5. Rest of Asia Pacific 11.9. Asia Pacific Digital Therapeutics Market Analysis, by Country/ Sub-region 11.10. China Digital Therapeutics Market Forecast, by Sales Channel 11.10.1. B2B 11.10.2. B2C 11.11. China Digital Therapeutics Market Forecast, by Application 11.11.1. Preventive Applications 11.11.2. Treatment/Care-Related Applications 11.12. India Digital Therapeutics Market Forecast, by Sales Channel 11.12.1. B2B 11.12.2. B2C 11.13. India Digital Therapeutics Market Forecast, by Application 11.13.1. Preventive Applications 11.13.2. Treatment/Care-Related Applications 11.14. Japan Digital Therapeutics Market Forecast, by Sales Channel 11.14.1. B2B 11.14.2. B2C 11.15. Japan Digital Therapeutics Market Forecast, by Application 11.15.1. Preventive Applications 11.15.2. Treatment/Care-Related Applications 11.16. ASEAN Digital Therapeutics Market Forecast, by Sales Channel 11.16.1. B2B 11.16.2. B2C 11.17. ASEAN Digital Therapeutics Market Forecast, by Application 11.17.1. Preventive Applications 11.17.2. Treatment/Care-Related Applications 11.18. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Sales Channel 11.18.1. B2B 11.18.2. B2C 11.19. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Application 11.19.1. Preventive Applications 11.19.2. Treatment/Care-Related Applications 11.20. Asia Pacific Digital Therapeutics Market Attractiveness Analysis 11.20.1. By Sales Channel 11.20.2. By Application 11.21. PEST Analysis 12. Middle East & Africa Digital Therapeutics Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Digital Therapeutics Market Overview 12.3. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Sales Channel 12.4. Middle East & Africa Digital Therapeutics Market Forecast, by Sales Channel 12.4.1. B2B 12.4.2. B2C 12.5. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Application 12.6. Middle East & Africa Digital Therapeutics Market Forecast, by Application 12.6.1. Preventive Applications 12.6.2. Treatment/Care-Related Applications 12.7. Middle East & Africa Digital Therapeutics Market Value Share Analysis, by Country 12.8. Middle East & Africa Digital Therapeutics Market Forecast, by Country 12.8.1. GCC 12.8.2. South Africa 12.8.3. Rest of Middle East & Africa 12.9. Middle East & Africa Digital Therapeutics Market Analysis, by Country/ Sub-region 12.10. GCC Digital Therapeutics Market Forecast, by Sales Channel 12.10.1. B2B 12.10.2. B2C 12.11. GCC Digital Therapeutics Market Forecast, by Application 12.11.1. Preventive Applications 12.11.2. Treatment/Care-Related Applications 12.12. South Africa Digital Therapeutics Market Forecast, by Sales Channel 12.12.1. B2B 12.12.2. B2C 12.13. South Africa Digital Therapeutics Market Forecast, by Application 12.13.1. Preventive Applications 12.13.2. Treatment/Care-Related Applications 12.14. Rest of Middle East & Africa Digital Therapeutics Market Forecast, by Sales Channel 12.14.1. B2B 12.14.2. B2C 12.15. Rest of Middle East & Africa Digital Therapeutics Market Forecast, by Application 12.15.1. Preventive Applications 12.15.2. Treatment/Care-Related Applications 12.16. Middle East & Africa Digital Therapeutics Market Attractiveness Analysis 12.16.1. By Sales Channel 12.16.2. By Application 12.17. PEST Analysis 13. Latin America Digital Therapeutics Market Analysis 13.1. Key Findings 13.2. Latin America Digital Therapeutics Market Overview 13.3. Latin America Digital Therapeutics Market Value Share Analysis, by Sales Channel 13.4. Latin America Digital Therapeutics Market Forecast, by Sales Channel 13.4.1. B2B 13.4.2. B2C 13.5. Latin America Digital Therapeutics Market Value Share Analysis, by Application 13.6. Latin America Digital Therapeutics Market Forecast, by Application 13.6.1. Preventive Applications 13.6.2. Treatment/Care-Related Applications 13.7. Latin America Digital Therapeutics Market Value Share Analysis, by Country 13.8. Latin America Digital Therapeutics Market Forecast, by Country 13.8.1. Brazil 13.8.2. Mexico 13.8.3. Rest of Latin America 13.9. Latin America Digital Therapeutics Market Analysis, by Country/ Sub-region 13.10. Brazil Digital Therapeutics Market Forecast, by Sales Channel 13.10.1. B2B 13.10.2. B2C 13.11. Brazil Digital Therapeutics Market Forecast, by Application 13.11.1. Preventive Applications 13.11.2. Treatment/Care-Related Applications 13.12. Mexico Digital Therapeutics Market Forecast, by Sales Channel 13.12.1. B2B 13.12.2. B2C 13.13. Mexico Digital Therapeutics Market Forecast, by Application 13.13.1. Preventive Applications 13.13.2. Treatment/Care-Related Applications 13.14. Rest of Latin America Digital Therapeutics Market Forecast, by Sales Channel 13.14.1. B2B 13.14.2. B2C 13.15. Rest of Latin America Digital Therapeutics Market Forecast, by Application 13.15.1. Preventive Applications 13.15.2. Treatment/Care-Related Applications 13.16. Latin America Digital Therapeutics Market Attractiveness Analysis 13.16.1. By Sales Channel 13.16.2. By Application 13.17. PEST Analysis 14. Company Profiles 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.3. Company Profiles: Key Players 14.3.1. Evolent Health, Inc. 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Business Strategy 14.3.1.4. Recent Developments 14.3.1.5. Manufacturing Footprint 14.3.2. Pear Therapeutics, Inc. 14.3.3. WellDoc Inc. 14.3.4. Nanobiosym, Inc. 14.3.5. Twine Health, Inc. 14.3.6. Mango Health Inc. 14.3.7. Canary Health Inc. 14.3.8. 2morrow Inc. 14.3.9. Propeller Health 14.3.10. Ginger.Io, Inc. 14.3.11. Noom Inc. 14.3.12. Livongo Health 14.3.13. Welldoc, Inc. 14.3.14. Omada Health, Inc. 14.3.15. Proteus Digital Health, Inc. 15. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID7003
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now